Effects of Drug Combinations on Recurrent or Refractory Rhabdomyosarcoma

Children's Oncology Group (COG)


Clinical Trial

Offered by: Nemours
Locations: Delaware Valley, Jacksonville, FL, Orlando, FL, Pensacola, FL

Trial Name

A Randomized Phase II Trial of Bevacizumab (Avastin) and Temsirolimus (Torisel) in Combination With Intravenous Vinorelbine and Cyclophosphamide in Patients With Recurrent/Refractory Rhabdomyosarcoma

What is the trial about?

Effects of drug combinations on recurrent or refractory Rhabdomyosarcoma.

Who can participate?

Children with recurrent or refractory Rhabdomyosarcoma.

What is involved?

Length of study up to 36 weeks. Standard cancer care.

Contact Nemours Clinical Trials

Trial Name: A Randomized Phase II Trial of Bevacizumab (Avastin) and Temsirolimus (Torisel) in Combination With Intravenous Vinorelbine and Cyclophosphamide in Patients With Recurrent/Refractory Rhabdomyosarcoma

COG#: ARST0921

Contact Information

(800) 354-5690
clinicaltrials@nemours.org